From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA skeptical of MRI contrast agent in babies

from MedPage Today

A gadolinium-based MRI contrast agent's proposed use in children younger than two appears to have very little data to support it, FDA staff reviewers said in briefing materials prepared for an advisory committee meeting. The review of gadoterate meglumine noted that only seven children younger than two had been included in maker Guerbet's clinical trial database. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063